DSCSA deadline on May 27—learn six urgent compliance moves, how smarter recall management becomes a competitive edge, how VRS lowers counterfeit risks, expert takes on tariffs, and more.
DSCSA enforcement begins May 27, 2025, and manufacturers and repackagers must act now to stay compliant and avoid shipment disruptions. LSPedia outlines six critical actions—like validating EPCIS connections, resolving exceptions, and leveraging OneScan—to protect your operations and keep products moving without delay.
DSCSA Enforcement Begins May 27: 6 Critical Actions to Protect Your Shipments
Why Recall Management Is a Strategic Imperative for Pharma Manufacturers
The Real Cost of Falling Behind on DSCSA Compliance
The Growing Threat of Counterfeit GLP-1 Medications – and the Role of VRS in Detection
Tariffs and Pharma: Strategies for Supply Chain Resilience and Compliance
Find LSPedia at CPHI North America 2025
Upcoming events and #LearnDSCSA: Webinars and Trainings
Why Recall Management Is a Strategic Imperative for Pharma Manufacturers
Product recalls aren’t just compliance events—they’re operational, financial, and reputational stress tests. In a high-stakes environment where speed and accuracy are non-negotiable, pharma manufacturers must treat recall readiness as a core competency. This blog dives into why modern recall management is more than just damage control—it’s a strategic advantage. Learn how leveraging automation, centralized data, and proactive response tools can minimize disruption and preserve trust.
The Real Cost of Falling Behind on DSCSA Compliance
With new DSCSA exemption deadlines approaching in 2025, trading partners face greater risks than ever for non-compliance — from shipment delays to lost business. This blog breaks down what’s at stake and how LSPedia’s OneScan and Investigator tools can help you automate serialization, resolve EPCIS errors, and stay audit-ready. Don’t let a data error derail your operations — turn compliance into your competitive advantage.
The Growing Threat of Counterfeit GLP-1 Medications – and the Role of VRS in Detection
Counterfeit GLP-1 medications are on the rise — even infiltrating trusted supply chains. As demand for weight loss and diabetes treatments like Ozempic and Wegovy grows, so does the opportunity for bad actors to jeopardize patient safety. Our latest blog explores how the Verification Router Service (VRS) helps distributors and dispensers detect fakes in real time, verify product authenticity directly with manufacturers, and stay compliant with DSCSA.
Tariffs and Pharma: Strategies for Supply Chain Resilience and Compliance
Tariffs, sourcing volatility, and increased regulatory scrutiny are shaking up the pharmaceutical supply chain. In this expert-led discussion, Riya Cao (CEO, LSPedia), Daniel MacKinnon (SVP of Sales & Marketing, LSPedia), and Ryan Kelly (Senior Director, Supply Chain Security & Brand Protection, Rx-360) explore how pharma leaders are using serialization and smart data to stay ahead of the disruption.
LSPedia is exhibiting at CPHI North America 2025, May 20–22 in Philadelphia. Stop by to see how our OneScan platform, powered by EPCIS and Investigator, simplifies DSCSA compliance and delivers real-time visibility with automated exception handling.
Meet Olivia Reindl and Katie Kelly onsite — and book a one-on-one to learn how we help trading partners reduce risk and keep operations running smoothly.
